Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis

This publication has 48 references indexed in Scilit:

• The hypothalamic–pituitary–gonadal axis and prostate cancer: implications for androgen deprivation therapy
  World Journal of Urology, 2013
• Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis
  BMC Cancer, 2013
• Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer
  Oncology Reports, 2011
• Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
  European Journal of Epidemiology, 2010
• Critical Review of Prostate Cancer Predictive Tools
  Future Oncology, 2009
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
  PLOS Medicine, 2009
• The prognostic value of hemoglobin change after initiating androgen‐deprivation therapy for newly diagnosed metastatic prostate cancer
  Cancer, 2006
• The impact of anaemia on outcome in cancer
  Clinical and Laboratory Haematology, 2005
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986